Karen A. Dun

St Vincent's Hospital Melbourne
Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Real-world application of the International Myeloma Society (IMS)/International Myeloma Working Group (IMWG) consensus on genomic staging for high-risk multiple myeloma: A report from the Australia and New Zealand Myeloma and Related Diseases Registry.

Real-world application of the International Myeloma Society (IMS)/International Myeloma Working Group (IMWG) consensus on genomic staging for high-risk multiple myeloma: A report from the Australia and New Zealand Myeloma and Related Diseases Registry.

Journal: British journal of haematology

Published: March 16, 2026

A multicenter study of progression risk and outcomes in solitary bone plasmacytoma with and without marrow involvement.

A multicenter study of progression risk and outcomes in solitary bone plasmacytoma with and without marrow involvement.

Journal: Blood advances

Published: November 18, 2025

Chronic lymphocytic leukemia with MDM2 amplification as an alternative pathway to TP53 dysfunction.

Chronic lymphocytic leukemia with MDM2 amplification as an alternative pathway to TP53 dysfunction.

Journal: Leukemia & lymphoma

Published: September 04, 2024

Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients.

Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients.

Journal: Clinical lymphoma, myeloma & leukemia

Published: July 05, 2024

Real-world utility of cytogenetic testing in cases with 'suspected myelodysplastic neoplasm but insufficient morphological features for diagnosis': a Victorian Cancer Cytogenetics Service experience.

Real-world utility of cytogenetic testing in cases with 'suspected myelodysplastic neoplasm but insufficient morphological features for diagnosis': a Victorian Cancer Cytogenetics Service experience.

Journal: Pathology

Published: May 21, 2024

Variant acute promyelocytic leukaemia with novel NAB2::RARA fusion shows clinical all-trans retinoic acid and arsenic trioxide sensitivity.

Variant acute promyelocytic leukaemia with novel NAB2::RARA fusion shows clinical all-trans retinoic acid and arsenic trioxide sensitivity.

Journal: British journal of haematology

Published: March 14, 2023

Comparing saliva and blood for the detection of mosaic genomic abnormalities that cause syndromic intellectual disability.

Comparing saliva and blood for the detection of mosaic genomic abnormalities that cause syndromic intellectual disability.

Journal: European journal of human genetics : EJHG

Published: September 07, 2022

Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.

Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.

Journal: Blood

Published: March 14, 2022

Concomitant diagnosis of chronic myeloid leukaemia and myeloma.

Concomitant diagnosis of chronic myeloid leukaemia and myeloma.

Journal: Pathology

Published: June 30, 2021

DSP30 and interleukin-2 as a mitotic stimulant in B-cell disorders including those with a low disease burden.

DSP30 and interleukin-2 as a mitotic stimulant in B-cell disorders including those with a low disease burden.

Journal: Genes, chromosomes & cancer

Published: September 20, 2017

BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1-positive B-cell acute lymphoblastic leukemia.

BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1-positive B-cell acute lymphoblastic leukemia.

Journal: Blood advances

Published: August 15, 2016

A second transmissible cancer in Tasmanian devils.

A second transmissible cancer in Tasmanian devils.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 30, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026